期刊文献+

短期应用阿托伐他汀对不稳定型心绞痛病人超敏C反应蛋白的影响 被引量:1

下载PDF
导出
摘要 目的观察短期应用阿托伐他汀对于不稳定型心绞痛病人超敏C反应蛋白(hs-CRP)的影响。方法116例不稳定型心绞痛病人随机分为两组。对照组应用常规药物治疗(包括硝酸酯类药物、抑制血小板聚集药物、β-受体阻滞剂、血管紧张素转换酶抑制剂、钙拮抗剂等),治疗2周;治疗组在常规治疗的基础上加阿托伐他汀20mg;每日1次口服,治疗2周。治疗前后测定三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)及hs-CRP的水平。结果治疗组经过2周的治疗后TG及HDL-C变化不明显(P>0.05);LDL-C、TC及hs-CRP显著下降(P<0.01)。对照组经过2周治疗血脂各指标及hs-CRP前后无明显改变。治疗组治疗前后hs-CRP的变化与血脂的变化无显著相关性(P>0.05)。结论短期应用阿托伐他汀治疗对LDL-C、TC及hs-CRP有显著降低作用。阿托伐他汀对于hs-CRP的降低作用与其对于血脂的降低作用不完全相关。
作者 乔梁
出处 《中西医结合心脑血管病杂志》 2008年第6期712-714,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献10

  • 1Ross R. Atherosclerosis: An inflammatory disease[J ]. N Engl J Med, 1999,340; 115 - 126.
  • 2Ridker PM. High - sensitivity, C-- reactive protein: Potenitial adjuct for global risk assessmenting the primary prevention of cardiovasular disease[J]. Circulation, 2001,103:1813 - 1818.
  • 3李江,赵水平,彭道泉,许竹梅,胡敏.急性心肌梗死早期普伐他汀治疗对血浆CD40L、金属蛋白酶-9及C反应蛋白的影响[J].中华心血管病杂志,2003,31(3):165-168. 被引量:100
  • 4Ess SM, Szucs TD. Medical - economical aspects of high- sensitivity C- reactive protein assay for the prediction of coronary heart disease: An analysis in Germany and Italy[J]. Ital Heart J ,2001,2(3) :181-188.
  • 5Koenig W,Sund M, Frohlich M, et al. C reative protein, a senstive marker of inflammation, predicts future risk of cornary heart disease in initially heathy middle agedd men: Resulte from the MONIKA Augsburg Cohort Study, 1984 - 1992[J]. Circulation, 1999,101 (2) :237 - 242.
  • 6Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C- reactive protein levels and cardiovascular disease [J] .Clin Sci(Lord) ,2000,98:531 - 535.
  • 7侯晓霞,贾三庆,王吉云,胡大一.高敏C反应蛋白检测与冠心病[J].中国医药导刊,2002,4(3):177-179. 被引量:15
  • 8Musial J, Undas A, Gajewski P, et al. Anti - inflommatory effects of simvastetin in subjects with hyper cholesterolemia[J ]. Int J Cardiol, 2001,77:247 - 253.
  • 9Albert MA, Danielson E,Rifai N, et al. Effect of statin therapy on C- reactive proteines[J]. Circulation, 2001,103:64 - 70.
  • 10Jialal Zstein D. Effect of hydroxmethyl glutaryl coenzyme: A reductase inhibitor therapy on high senstive C- reactive protein levels[J]. Circulation, 2001,103 : 1933 - 1935.

二级参考文献16

  • 1Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Nail Acad Sci USA, 2000, 97: 7458-7463.
  • 2Lutgens E, Cleutjens KBJM, Heeneman S, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Nail Aced Sci. USA, 2000, 97: 7464-7469.
  • 3Kai H,Ikeda H, Yasukawa H, et al. Perpherial blood levels of matrix metalloproteinase-2 and 9 are evelated In patients with acute coronary sndrome. J Am Coll Cardiol , 1998,32:368-372.
  • 4Taku T, Toshio H, Hatsuyo K, et al. Cerivastatin, a HMG-CoA Reductase Inhibitor, Improves Endothelial Function In Elderly Diabetics winthin 3 days. Circulation, 2001,104:376-379.
  • 5Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999,340: 115-126.
  • 6Goran K Hansson. Immune Mechanism In Atherosclerosis Arteroscler Thromb Vasc Biol . 2001,21:1876-1890.
  • 7Koefig W. Inflammation and coronary heart disease:an overview Cardiol Rev, 2001,9:31-35.
  • 8Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 1997,96:396-399.
  • 9Brown DL, Hibbs MS, Kearney M, et al. Identification 92 kDa gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation , 1995, 91: 2125-2131.
  • 10Chalmers J, WHO-ISH Hypertension Guidelines Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for Management of Hypertension. J Hypertens, 1999,17:151-183.

共引文献113

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部